Robert M. Patterson - Feb 11, 2022 Form 4 Insider Report for AVIENT CORP (AVNT)

Role
Chairman, President & CEO, Director
Signature
/s/ Lisa K. Kunkle, Power of Attorney For: Robert M. Patterson
Stock symbol
AVNT
Transactions as of
Feb 11, 2022
Transactions value $
-$1,226,354
Form type
4
Date filed
2/15/2022, 04:20 PM
Previous filing
Aug 30, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNT Common Stock Options Exercise +49K +9.8% 548K Feb 11, 2022 Direct F1, F2
transaction AVNT Common Stock Tax liability -$1.23M -23.3K -4.25% $52.64 525K Feb 11, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVNT Restricted Stock Units Options Exercise -49K -50% 49K Feb 11, 2022 Common Stock 49K Direct F1
transaction AVNT Restricted Stock Units Award $0 +38.2K $0.00 38.2K Feb 14, 2022 Common Stock 38.2K Direct F1
transaction AVNT Stock Appreciation Rights Award $0 +135K $0.00 135K Feb 14, 2022 Common Stock 135K $52.64 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Avient common stock.
F2 Includes dividend equivalents earned with respect to the vested restricted stock units.
F3 Represents shares of Avient common stock that were withheld solely to satisfy the tax withholding obligation applicable to the vesting of restricted stock units on February 11, 2022.
F4 SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.